|
US2020085819A1
|
|
Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
|
|
EP3506924A2
|
|
nNIF AND nNIF-RELATED PEPTIDES AND RELATED METHODS
|
|
CN108699602A
|
|
The method for identifying male's fertilizability state and embryo quality
|
|
US2017268997A1
|
|
Chemical probes for hydrogen sulfide
|
|
US2015236643A1
|
|
Systems and methods for fault detection
|
|
NZ715331A
|
|
Substituted (e)-n’-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
|
|
US2015126604A1
|
|
Branched chain amino acids: formulations and methods of treatment
|
|
EP2861732A2
|
|
Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
|
|
AU2013260056A1
|
|
Compounds with TRPV4 activity, compositions and associated methods thereof
|
|
AU2012321345A1
|
|
Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
|
|
AU2010239272A1
|
|
Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
|
|
AU2008201914A1
|
|
Coil optimization for magnetic stimulation
|
|
AU2005202495A1
|
|
Elastin-based compositions
|
|
AU2005233643A1
|
|
Biodegradable and biocompatible PEG-based poly(ester-urethanes)
|
|
AU2003230715A1
|
|
In vivo use of glutathionone s-transferase activated nitric oxide donors
|
|
AU2002309073B2
|
|
Generation, characterization, and isolation of neuroepithelial stem cells and lineage restricted intermediate precursor
|
